| 摘要 |
A pharmaceutical composition containing a triazole compound which is (2R,3R)-3-[[trans-2-[(1E,3E)-4-(4-cyano-2-fluorophenyl)-1,3-butadien-1-yl]-1,3-dioxan-5-yl]thio]-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol and at least one pharmaceutically acceptable basic substance, wherein a ratio of the triazole compound to the basic substance is 1:0.01 to 1:10; the triazole compound is in an amount of 1 to 2000 mg; and the composition has an improved stability compared to the stability of the triazole compound by itself.
|
